Chinese Journal of New Drugs 2010 Issue 19 Effect of piperonal amino-s-triazole Schiff base on apoptosis of hepatocarcinoma BEL-7402 cells

Effect of piperonal amino-s-triazole Schiff base on apoptosis of hepatocarcinoma BEL-7402 cells
CHEN Bai-quan1;2;HUANGFU Chao-shen1

..............page:1803-1806

S-1 in the treatment of gastrointestinal cancer
ZHANG Ning-ning;GUO Xiao-zhong

..............page:1774-1777

Advances in the relationship between antidiabetic drugs and pancreatic cancer
LI Wei-guang;YUAN Yao-zong

..............page:1771-1773

Determination of imidol hydrochloride in human plasma by LC-MS/MS and its pharmacokinetics
YANG Chen1;LI Yang2;ZHANG Tian-hong1;CHEN Xiao-hui1;BI Kai-shun1;LI Ke-xin2;HU Xin2

..............page:1747-1749,1770

Progress in novel drugs in the treatment of visceral hypersensitivity
WEI Lei;GAO Jun;XU Guo-ming

..............page:1758-1761

Preventive effect of folate on colorectal cancer
ZHAO Hai-xia;PENG Gui-yong;FANG Dian-chun

..............page:1762-1766

Preventive effect of low-dose esomeprazole on recurred reflux esophagitis
DU Shi-yu1;2;BAi Ru-xue2;FANG Long2;YAO Shu-kun2

..............page:1785-1787

Antibacterial mechanism of the extracts of green tea combined with cephazoline on MRSA
HUA De-xing1;3;XU Xiao-ling2;PENG Qing1;YAO Fen1;QIAN Yuan-shu1

..............page:1807-1810

Current status of pharmacokinetics and clinical study of silybin-phospholipid complex
LIANG Ming-xin1;CAI Xue-hong2

..............page:1778-1780,1813

Analysis of adjuvant chemotherapy for gastric cancer with oxaliplatin plus capecitabine
ZHANG Lu;GUAN Mei;ZHAO Lin;BAI Chun-mei

..............page:1781-1784,1787

Protective effect of hyperin on CCl₄-induced hepatic injury in mice
KONG Hua-li1;4;HU Ke-zhang2;4;YANG Xin-bo3;HUANG Zheng-ming1

..............page:1794-1797,1820

Severe hepatic injury induced by flutamide: a report of 3 cases
WU Ping1;XIA Wei2;ZHUANG Qian-feng2;WANG Ming-li1;ZOU Su-lan1;XU Jian-ping1

..............page:1821-1822

WINDOW OF NEW DRUGS

..............page:1732-1733

Subsequent anti-viral therapy in patients with chronic hepatitis B following resistance to initial lamivudine treatment
FAN Xiao-tang;SUN Li-hua;FAN Xiao-wen;MA Qing-he;ZHANG Yue-xin

..............page:1788-1790,1793

Clinical efficacy of silybin in 168 patients with fatty liver
ZHANG Xin-hua;Sajidanmu;XIE Dang-en

..............page:1791-1793

The application of biological target drugs in treatment of inflammatory bowel disease
LI Shi-rong

..............page:1750-1757

juan shou yu

..............page:1731

Modulating effect of β-glycyrrhetic acid on the activity of farnesoid X receptor
LIU Wen-ming1;WANG Hai-bin2;LIU Li3;ZHOU Xi1;WANG Jun-jian1

..............page:1798-1802

Progression in research of molecular targeted therapy for pancreatic cancer
GUO Zi-hao;HAO Jian-yu

..............page:1767-1770

Synthesis of 5-acetamido-N,N'-bis（2,3-dihydroxypropyl）-2,4,6-triiodo-isophthalamide
ZHANG Ting-ting1;XU Jing-jing1;LIU Ming-liang2

..............page:1811-1813

ben qi dao du

..............page:1726

Design and development of dry power inhalers
MENG Bo-yu1;XU Xiang-yang1;2;WANG Qing-song1;3

..............page:1738-1743

Efficacy and safety of adalimumab in Crohn's disease
HAN Ying

..............page:1734-1737

The communication during innovative drug research and development and review
YANG Jian-hong;SHI Ji-feng;WEN Bao-shu;HE Yan-ping;FENG Yi

..............page:1744-1746,1802

Study on an active hepatocyte-targeting antineoplastic activity of norcantharidin-loaded galactosylated chitosan nanoparticles
HU Wei1;ZHANG Liang2;WANG Qin1;CHEN Xiao-yan1;BEI Yong-yan1;XU Jing-yu3;WANG Wen-juan1;ZHANG Xue-nong1

..............page:1814-1820